Headlines | WebDisclosure

Basculer en Français

10228	Companies
211134	Keywords
141057	Articles
111847	Press releases

BRIEF

published on 04/16/2026 at 20:40, 22 minutes ago

Drägerwerk AG & Co. KGaA Sees Significant Earnings Boost in Q1 2026

Q1 2026 Results Drägerwerk Earnings Medical Division Performance Safety Division Growth 2026 Fiscal Forecast
BRIEF

published on 04/16/2026 at 20:40, 22 minutes ago

Drägerwerk AG & Co. KGaA prévoit une forte hausse de ses bénéfices au premier trimestre 2026

Résultats Du T1 2026 Revenus De Drägerwerk Performance Du Service Médical Croissance De La Division Sécurité Prévisions Budgétaires Pour 2026
PRESS RELEASE

published on 04/16/2026 at 20:35, 27 minutes ago

EQS-Adhoc: Correction of a release from 16/04/2026, 19:17 CET/CEST - Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Drägerwerk AG & Co. KGaA reports Q1 2026 preliminary results: strong earnings growth, net sales increase, and positive EBIT margin. Forecast for 2026 includes higher sales and EBIT margin

Net Sales EBIT Margin Earnings Growth Drägerwerk AG Q1 2026
BRIEF

published on 04/16/2026 at 19:25, 1 hour 37 minutes ago

AB Science : Point sur le Programme Clinique et Suspension Stratégique

Assurance Reorganisation Essais Cliniques AB Science SLA
BRIEF

published on 04/16/2026 at 19:25, 1 hour 37 minutes ago

AB Science Secures Insurance for Clinical Trial Despite Halt in Europe

AB Science Clinical Trial Insurance ALS Phase III Masitinib Program European Health Authorities
BRIEF

published on 04/16/2026 at 19:25, 1 hour 37 minutes ago

AB Science: Update on the Clinical Program and Strategic Suspension

Insurance Clinical Trials Reorganization ALS AB Science
BRIEF

published on 04/16/2026 at 19:25, 1 hour 37 minutes ago

AB Science obtient une assurance pour son essai clinique malgré son interruption en Europe

Sciences AB Assurance Pour Essais Cliniques SLA Phase III Programme Masitinib Autorités Sanitaires Européennes
BRIEF

published on 04/16/2026 at 19:22, 1 hour 40 minutes ago

Drägerwerk AG Reports Significant Earnings Growth in Q1 2026

Net Sales Growth Order Intake EBIT Increase Drägerwerk AG Q1 2026 Earnings
BRIEF

published on 04/16/2026 at 19:22, 1 hour 40 minutes ago

Drägerwerk AG annonce une forte croissance de ses bénéfices au premier trimestre 2026

Croissance Des Ventes Nettes Drägerwerk AG Prise De Commande Augmentation Du Résultat D'exploitation Résultats Du Premier Trimestre 2026
PRESS RELEASE

published on 04/16/2026 at 19:20, 1 hour 42 minutes ago

AB Science fait le point sur son programme de développement clinique
AB Science obtient une assurance d'essais cliniques de 25 millions d'euros pour son étude de phase III sur la sclérose latérale amyotrophique et met en place une suspension temporaire de ses essais cliniques en Europe

Assurance Europe Étude Clinique AB Science Sclérose Latérale Amyotrophique

Accesswire

Published on 04/16/2026 at 15:55, 5 hours 8 minutes ago

TripSitter Announces Director Resignation
Published on 04/16/2026 at 15:20, 5 hours 43 minutes ago

Datavault AI Goes Live with First Edge GPU Sites in New York and Philadelphia; $1.44B-$1.92B Quantum-Ready Fleet to Reach 100+ U.S. Cities by End of 2026
Published on 04/16/2026 at 15:00, 6 hours 3 minutes ago

FaZe Esports, a GameSquare Company, Announces Partnership with CORSAIR
Published on 04/16/2026 at 14:44, 6 hours 19 minutes ago

Worksport to Showcase SOLIS(TM), COR(TM) and Expanded Product Line at the 2026 MOORE Overlanding Expo
Published on 04/16/2026 at 14:35, 6 hours 28 minutes ago

LQR House Inc. Announces Agreement to Acquire 100% of Fusion Five Continents Limited, a Next-Generation Cross-Border Securities and Digital Asset Trading Platform

View all ACCESSWIRE

EQS Group

Published on 04/16/2026 at 20:35, 27 minutes ago

EQS-Adhoc: Correction of a release from 16/04/2026, 19:17 CET/CEST - Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 19:17, 1 hour 45 minutes ago

EQS-Adhoc: Drägerwerk AG & Co. KGaA: Preliminary figures Q1 2026: Earnings significantly above prior year
Published on 04/16/2026 at 18:57, 2 hours 6 minutes ago

Op-Ed: Africa’s Energy Wealth: Why Good Governance Must Power a Just Transition (By Sola Adebawo)
Published on 04/16/2026 at 18:06, 2 hours 57 minutes ago

SIG Group AG holds 2026 Annual General Meeting
Published on 04/16/2026 at 18:00, 3 hours 2 minutes ago

Annual general meeting 2026: all proposals of the board of directors approved; Stefan Scheiber elected chairman of the board

Les Echos

Published on 04/16/2026 at 18:02, 3 hours 1 minute ago

Covivio - Description of the share buy-back program authorized by the Combined Ordinary and Extraordinary Shareholders’ Meeting held on 16 April 2026
Published on 04/16/2026 at 18:02, 3 hours 1 minute ago

Covivio - Descriptif du programme de rachat d’actions autorisé par l’Assemblée Générale Mixte des actionnaires du 16 avril 2026
Published on 04/16/2026 at 18:00, 3 hours 3 minutes ago

ICADE – PR – Q1 2026 TRADING UPDATE
Published on 04/16/2026 at 18:00, 3 hours 3 minutes ago

ICADE – CP – ACTIVITE AU 31 MARS 2026
Published on 04/16/2026 at 17:55, 3 hours 7 minutes ago

Publication of 2026 1st quarter turnover

View all LES ECHOS COMFI WIRE